Financial Snapshot
What does Exelon Corporation’s latest financial snapshot show?
Mixed. The strongest factor is regulated earnings stability, while the main concern is the need for large external funding to support the capital plan.
For Q1 2026, Exelon Corporation’s snapshot combines growth, profitability, cash generation, balance-sheet capacity, and capital efficiency, with full-year 2025 context still useful for scale. For company background, see Exelon Corporation (EXC): History, Ownership, Mission, How It Works & Makes Money.
Full-year 2025 revenue was $2394B, net income was $273B, and adjusted operating earnings were $277 per share; in Q1 2026, GAAP net income was $090 per share, adjusted operating earnings were $091 per share, and total net income was $930M. The $417B capital plan for 2026–2029 makes funding capacity and execution the key watch item.
The first metric to analyze more closely is free cash flow, because it shows whether Exelon Corporation can fund growth without leaning too heavily on outside capital.
Revenue and earnings quality
Is Exelon Corporation’s revenue growth producing quality earnings?
Mixed. Revenue growth is backed by a regulated utility model, but the clearest confirmation comes from operating income and EPS rising sharply in Q1 2026. The main divergence is that earnings quality still depends on approved rate recovery across concentrated jurisdictions.
Exelon’s growth is more about durability than speed. Investors compare revenue with operating income, net income, and EPS across the same annual periods to see whether higher sales translate into better margins, stronger per-share results, and less dependence on one-time factors or regulatory timing.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $724B in Q1 2026; 3381% growth | Prior comparable Q1 2025 revenue was not provided | Unclear from the prompt, but supported by regulated distribution and decoupled revenue | Repeatable if rate recovery continues, but the exact growth driver is not fully separated |
| Operating Income | $161B in Q1 2026; 3590% growth | Prior comparable Q1 2025 operating income was not provided | Grew faster than revenue | Suggests operating leverage and better earnings quality |
| Net Income | $91900M in Q1 2026; 5471% growth | Prior comparable Q1 2025 net income was not provided | Supported by regulated earnings and approved rates; tax, interest, or unusual-item detail was not provided | Final earnings confirm the operating result, but the driver mix is incomplete |
| Diluted EPS | $090 in Q1 2026; 5254% growth | Prior comparable Q1 2025 diluted EPS was not provided | Share-count effect was not provided | Per-share growth was strong, so shareholders saw the operating improvement |
How durable is Exelon Corporation’s revenue?
Strong. The best durability signal is Exelon’s six fully regulated utilities, plus decoupled revenue for ComEd and BGE, which reduces weather and usage swings. The biggest limitation is concentration in regulated jurisdictions and reliance on approved recovery.
- Demand Quality: Revenue is recurring because Exelon serves about 10.7M electric and gas customer accounts through regulated utilities.
- Pricing and Volume: Growth is mainly tied to approved distribution rates and recovery, while the split between price, volume, and mix was not provided.
- Diversification: Exelon is diversified across Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco, but it remains concentrated in regulated businesses and jurisdictions.
That structure usually supports steadier cash flow and better profit conversion.
Cash Quality
Do Exelon’s profits convert into usable cash?
The supplied data do not verify margin changes, and the cash-flow dollar figures are missing, so full confirmation is incomplete. Still, Operating Cash Flow Growth 3859% and Free Cash Flow Growth 4672% suggest stronger cash conversion, even as Interest Expense of $55500M pressured profit.
Gross profit, EBIT, operating income, and net income all show accounting profitability, but margins are not provided here, so they should be derived in a later model if needed. Cash quality is harder to judge because operating cash flow, capital expenditures, and free cash flow dollar amounts are not supplied, even though growth rates are very strong.
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | Not provided for Q1 2026 | Not provided | Revenue of $724B and Gross Profit of $205B are supplied, but no verified margin input or pricing and mix breakout is provided. | The trend in product economics cannot be confirmed from the supplied data alone. |
| Operating Margin | Not provided for Q1 2026 | Not provided | Operating Income of $161B is supplied, but the margin is not provided and should be derived only in a later model. | Scale may be improving, but operating efficiency cannot be verified from the given inputs. |
| Net Margin | Not provided for Q1 2026 | Not provided | Net Income of $91900M was reduced by Interest Expense of $55500M, which management said was a primary headwind. | Final profitability is under pressure from financing costs, so earnings quality needs cash support. |
| Operating Cash Flow | Growth rate only: 3859% for 2026-03-31 | Growth rate only: previous comparable period not provided | The supplied data do not include operating cash flow dollar amounts, but management indicated higher interest expense was a headwind to earnings. | Directional improvement suggests better cash conversion, but the full earnings-to-cash bridge is unavailable. |
| Free Cash Flow | Growth rate only: 4672% for 2026-03-31 | Growth rate only: previous comparable period not provided | The $417B capital plan can support rate base growth, but it also reduces internally available cash after reinvestment. | Cash remaining after investment may be tight, so reinvestment discipline matters. |
What most affects Exelon’s cash conversion?
The biggest verified drivers are the $417B capital plan and Interest Expense of $55500M, which raise reinvestment needs and financing pressure. That looks structural, not temporary, but the cash-flow dollar bridge is still missing.
- Main Driver: The capital plan and interest burden dominate cash conversion; both appear structural because they are tied to utility investment and financing needs.
- Evidence Gap: The supplied data do not include operating cash flow, capital expenditures, or free cash flow dollar amounts.
- Metric to Monitor: Track operating cash flow versus capital expenditures, plus operating margin once it is derived.
If you’re using this topic for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help you organize the research into clear arguments. For deeper academic or investment research, a DCF valuation model or company financial analysis template can help connect Exelon’s strategy with revenue, margins, cash flow, and valuation assumptions. Exploring Exelon Corporation (EXC) Investor Profile: Who's Buying and Why?
Debt and Liquidity
Can Exelon Corporation’s balance sheet support its obligations and investment needs?
Exelon Corporation is Mixed. The main protection is active financing access, including the February 20, 2026 $775M senior notes issue, while the main concern is rising leverage and dilution pressure from the $34B equity plan.
Cash helps, but it does not tell the full story. Exelon Corporation’s balance sheet needs to be viewed through debt service, refinancing access, asset quality, and the pace of required funding. The company’s recent financing activity shows access to capital, but it also signals that ongoing obligations and investment needs still depend on external funding. For investors tracking ownership and sentiment, Exploring Exelon Corporation (EXC) Investor Profile: Who's Buying and Why? adds useful context.
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | 2026-03-31 Cash And Cash Equivalents of $127B; prior periods were $115B at 2025-12-31, $205B at 2025-09-30, and $72400M at 2025-06-30. | Mixed | Cash supports near-term flexibility, but this data alone does not prove that obligations can be met without strain. |
| Total and Net Debt | 2026-03-31 Total Debt of $5124B; prior periods were $5055B at 2025-12-31, $5027B at 2025-09-30, and $4884B at 2025-06-30. | Mixed | Leverage is still rising, which can limit flexibility even when financing access remains open. |
| Debt Service and Refinancing | February 20, 2026 issuance of $775M of 4.95% Senior Notes due March 15, 2036 to repay existing debt and fund general operations; 430% of planned 2026 debt financings completed. | Mixed | Exelon Corporation can still tap funding markets, but refinancing needs remain a live issue. |
| Asset Quality | No verified receivables, inventory, goodwill, intangibles, or impairment data supplied in this prompt. | Mixed | Asset-quality risk cannot be fully judged from the provided figures alone. |
| Liabilities and Equity | $34B equity plan through 2029; about $850M in annualized equity needs; 370% of total equity needs already priced through 2029. | Mixed | The capital base is being supported, but equity funding can dilute shareholders. |
What balance-sheet risk matters most for Exelon Corporation?
Refinancing and dilution risk matter most. Exelon Corporation has access to funding, but the growing debt load and the $34B equity plan make ongoing capital raises the key pressure point.
- Current Exposure: $5124B total debt versus $127B cash at 2026-03-31; debt growth was 136%.
- Protection: 430% of planned 2026 debt financings completed, plus 370% of total equity needs priced through 2029.
- Warning Signal: Watch whether debt keeps rising faster than cash and whether future equity raises increase dilution pressure.
Regulated Capital Returns
Are Exelon’s reinvestment needs financially sustainable?
Capital efficiency looks Mixed, because Exelon’s returns are driven by regulated investment rather than supplied ROIC, ROE, or ROA ratios, and internal cash may not fully cover reinvestment needs given the $417B 2026–2029 capital plan and planned $34B of equity through 2029.
Return analysis has to account for leverage, capital intensity, capital expenditure, working capital, and outside funding. For Exelon, that means judging regulated rate-base growth, transmission spending, and equity funding together rather than treating returns as a simple margin story. The company’s structure can support steady investment, but it also requires ongoing access to capital.
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | ROIC is not supplied; use conceptually in a later model alongside the $681B estimated 2026 rate base. | Regulated capital deployment can support value if allowed returns and asset growth stay constructive. | Invested capital appears to create operating value when rate-base growth is matched by disciplined spending. |
| ROE and ROA | ROE and ROA are not supplied; they should be kept separate from ROIC in a later financial model. | ROE can rise with leverage, while ROA is constrained by asset intensity in utility operations. | Shareholder return quality depends on leverage discipline, not just equity returns alone. |
| Maintenance and Growth Investment | The $417B 2026–2029 capital plan includes $11B deferred at PECO and BGE and $15B of incremental transmission investments. | The mix shows both network maintenance and growth, but the growth push is still the larger strategic driver. | Capital needs appear heavy, but they are tied to regulated load growth and grid expansion. |
| Internal Funding Capacity | Exelon plans $34B of equity through 2029 and paid a regular quarterly dividend of $0.42 per share on June 15, 2026. | That points to partially internally funded investment, with outside capital still needed. | Outside funding can preserve execution, but it also limits flexibility and can dilute common shareholders. |
Are Exelon’s returns on capital sustainable?
Yes, if regulated rate-base growth and transmission spending keep earning allowed returns; the main pressure point is the $34B equity plan, which means reinvestment is not fully self-funded.
- Operating Source: Regulated capital deployment, estimated $681B 2026 rate base, and transmission rate base growth at a 160% CAGR through 2029.
- Funding Requirement: The $417B 2026–2029 capital plan, plus the $15B incremental transmission investments and the AI and data center electricity procurement strategy.
- Durability Test: Returns would weaken if equity needs keep rising, if project deferrals expand beyond $11B, or if allowed returns do not keep pace with capital intensity.
Financial Resilience
How resilient is Exelon Corporation, and which warning signs matter most?
Exelon Corporation looks Mixed. Its main buffer is regulated utility revenue with recovery mechanisms and financing progress, but the most important verified warning sign is higher interest expense, which management said hurt Q1 2026 earnings at the holding company and PECO.
Exelon’s resilience depends on whether regulated earnings and allowed recovery keep pace with rising financing and execution demands. The business can still support liquidity and essential investment, but higher rates, delayed project timing, or weaker collections would tighten debt service and free cash flow. The link between regulation and cash recovery matters most.
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | Higher interest expense reduces operating leverage, lowers earnings and cash flow, and can limit debt capacity if utility returns do not offset it. | Regulated revenue, decoupled revenue at ComEd and BGE, and recovery mechanisms for the $681B estimated 2026 rate base support earnings stability. | Any further rise in interest expense, weaker utility earnings, or slower cash conversion would confirm deterioration. |
| Working-Capital or Investment Pressure | Credit losses, deferred projects, and front-loaded procurement for long-lead items can absorb cash before recovery shows up in rates. | BGE reported approved distribution rates for infrastructure recovery, and Exelon has completed financing progress that helps fund investment. | Rising operating-cash-flow strain, larger deferred project balances, or slower procurement and project execution would be the key signals. |
| Interest or Refinancing Pressure | Interest expense directly affects earnings, free cash flow, and refinancing flexibility, especially at the holding company. | Regulated cash flows and recovery mechanisms provide support, and utility rate cases can eventually reset recovery. | Higher interest expense, tighter coverage, or weaker access to financing would show rising pressure. |
Which financial warning signs should investors monitor at Exelon Corporation?
The strongest signals are higher interest expense, rising credit loss expense, and project timing slippage. The first two are confirmed pressure points; the third is a future risk if procurement delays and deferred projects start pushing out recovery.
Higher Interest Expense
Management said higher interest expense affected Q1 2026 earnings at the holding company and PECO, so this is the clearest near-term pressure. The offset is regulated recovery, but investors should watch interest expense, coverage, and refinancing needs.
Credit Loss Expense at BGE
BGE reported an increase in credit loss expense, which cut quarterly operating earnings. That matters because utility cash flow depends on collections staying stable. The next metric to monitor is whether credit loss expense keeps rising or normalizes.
Execution and Procurement Timing
Geopolitical shifts have affected transformer supply and infrastructure equipment lead times, making front-loaded procurement important. With $11B in deferred projects at PECO and BGE and $15B in incremental transmission investments, delays could push out cash recovery and strain investment timing.
Financial Health Scorecard
How healthy is Exelon Corporation financially for investors?
Exelon Corporation rates Mixed. The strongest factor is regulated earnings durability from utility rate design and decoupling, while the weakest is the funding burden from capex, debt service, and equity needs. The most important condition is whether cash flow can keep pace with heavy regulated investment.
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Strong | Regulated T&D utilities, about 107M customer accounts, and decoupled revenue at ComEd and BGE support recurring earnings. Q1 2026 Adjusted Operating Earnings of $0.91 per share and guidance of $2.81 to $2.91 per share show stable per-share delivery. |
| Profitability and Cash | Mixed | Q1 2026 Operating Income of $1.61B is solid, but Net Income of $91900M, Interest Expense of $55500M, and heavy capital spending limit usable cash and free-cash-flow flexibility. |
| Balance Sheet and Liquidity | Mixed | Exelon has financing access and $775M of 4.95% Senior Notes due March 15, 2036, but Total Debt of $5124B and planned $34B equity needs keep funding pressure high. |
| Capital Efficiency | Mixed | The $417B capital plan can expand regulated rate base, but large external funding needs and possible dilution must be justified by allowed returns and execution. |
| Financial Resilience | Mixed | Regulated mechanisms, decoupling, and financing progress help absorb pressure, but interest expense, credit loss expense, and procurement timing remain the main warning signs. |
- What Supports the Thesis: Regulated utility earnings, decoupled revenue, and guidance of $2.81 to $2.91 per share give Exelon a durable earnings base.
- What Challenges the Thesis: Heavy debt, high interest expense, and $34B of equity needs create the biggest drag on financial flexibility.
- What to Monitor: Adjusted Operating Earnings per share versus guidance, Interest Expense versus $55500M, and progress against the $417B capital plan and $34B equity plan.
That makes forecasts, scenarios, and valuation depend on how well Exelon matches regulated returns with funding needs, which is why a linked strategy view like Mission Statement, Vision, & Core Values (2026) of Exelon Corporation (EXC) can help frame the execution risk.
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
How do decoupled revenues stabilize Exelon earnings?
Decoupled revenue mechanisms at ComEd and BGE reduce the link between distribution earnings and actual weather or customer usage variations That supports more stable regulated earnings, although Exelon still depends on approved rates, cost recovery, interest expense management, and capital execution
Why is Exelon adding equity through 2029?
Exelon updated its 2026–2029 financing plan to include $34B of equity, aiming for approximately $850M in annualized equity needs The planned equity helps fund the $417B capital plan, but it also creates dilution pressure investors should monitor
What does higher interest expense do to EXC?
Higher interest expense reduces the earnings left after operating income and other items In Q1 2026, Exelon reported Interest Expense of $55500M, and management identified higher interest expense as a primary headwind affecting the holding company and PECO
Can Exelon fund grid growth without liquidity strain?
Exelon has shown financing access through debt issuance and planned equity pricing progress It completed 430% of planned 2026 debt financings and priced 370% of total $34B equity needs through 2029, but the $417B capital plan keeps liquidity planning important
Which return metrics matter most for Exelon?
ROIC, ROE, and ROA each answer a different question ROIC tests returns on operating capital, ROE tests returns to shareholders, and ROA tests asset productivity Supplied data does not provide those ratios, so investors should model them separately